Allakos Investigational Site

Durham, North Carolina 27710

0 studies enrolling now · 4 studies all time

What they study most

Eosinophilic Duodenitis, Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis

Studies at this site

• A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) — Completed
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis — Completed
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis — Completed
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis — Withdrawn before enrolling